The resulting transgenic mouse model, Alzheimer’s disease-like pathology with APP, PSEN1, and MAPT transgenes (ADLPAPT), exhibited Aβ accumulation, NFTs, early neuronal loss in the brain, and subsequent memory impairments. This evidence concerns the gene MAPT and Alzheimer disease.